Raffles Medical Group H1 2021 Performance
SG's Raffles Medical Group revenue surges to $343.8m in H1
SG's Raffles Medical Group revenue surges to $343.8m in H1
The group’s profits after tax ballooned by as much as 138.4%.
Most Read
1. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 2. Asian medical device markets face cost shocks amidst Iran conflict 3. Global dental articulators market to reach $227.8m by 2030 4. Neurological disorders and aging boost brain-computer interface market 5. AJJ Medtech hits $8m order book with $3m green supply dealResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation